Condition: Gallbladder Neoplasms
Intervention: Drug: Somatostatin
Sponsors: Shanghai Jiao Tong University School of Medicine; Xuanwu hospital capital medical university; Beijing friendship hospital affiliate of capital university of medical sciences; Peking University First Hospital; Tianjin Medical University Cancer Institute and Hospital; First affiliated hospital of Dalian medical university; The First Hospital of China Medical University; The first clinical college of harbin medical university; The 2nd affiliated hospital of harbin medical university; Shengjing hospital of china medical university; China-Japan union hospital of jilin university; The people’s hospital of Heilongjiang province; Eastern Hepatobiliary Surgery Hospital; Shanghai Changzheng Hospital; Shandong Provincial Hospital; Qilu hospital of Shandong university; Xijing hospital of The fourth military medical university; Tangdu hospital of The fourth military medical university; Qinghai povince people’s hospital; Qinghai university affiliated hospital; The first affiliated hospital, Chongqing medical university; Daping hospital of the third military medical university; Kungming the first people’s hospital; Lanzhou university second hospital; Xi'an Center Hospital; The first people’s hospital of Guiyang; Southwest hospital of the third military medical university; Xinqiao hospital of the third military medical university; The first affiliated hospital of kunming medical college; The second affliated hospital of kunming medical college
Recruiting - verified October 2009